ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Follicle Stimulating Hormone Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-0J9577
Home | Market Reports
Global Follicle Stimulating Hormone Market Insights and Forecast to 2028
BUY CHAPTERS

Global Follicle Stimulating Hormone Market Research Report 2026

Code: QYRE-Auto-0J9577
Report
2026-01-23
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck Serono
MSD
IBSA
Ferring
LIVZON
Techwell
GenSci
Gedeon Richter
TEVA

Follicle Stimulating Hormone Market Size

The global Follicle Stimulating Hormone market was valued at US$ 1381 million in 2025 and is anticipated to reach US$ 1671 million by 2032, at a CAGR of 2.8% from 2026 to 2032.

Follicle Stimulating Hormone Market

Follicle Stimulating Hormone Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Follicle Stimulating Hormone competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
This report delivers a comprehensive overview of the global Follicle Stimulating Hormone market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Follicle Stimulating Hormone. The Follicle Stimulating Hormone market size, estimates, and forecasts are provided in terms of sales volume (K Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Follicle Stimulating Hormone market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Follicle Stimulating Hormone manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Follicle Stimulating Hormone Market Report

Report Metric Details
Report Name Follicle Stimulating Hormone Market
Accounted market size in 2025 US$ 1381 million
Forecasted market size in 2032 US$ 1671 million
CAGR 2.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Recombinant FSH
  • Urinary FSH
by Application
  • Infertility Treatment
  • Assisted Reproductive Technology
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Follicle Stimulating Hormone manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Follicle Stimulating Hormone sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Follicle Stimulating Hormone Market growing?

Ans: The Follicle Stimulating Hormone Market witnessing a CAGR of 2.8% during the forecast period 2026-2032.

What is the Follicle Stimulating Hormone Market size in 2032?

Ans: The Follicle Stimulating Hormone Market size in 2032 will be US$ 1671 million.

Who are the main players in the Follicle Stimulating Hormone Market report?

Ans: The main players in the Follicle Stimulating Hormone Market are Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva

What are the Application segmentation covered in the Follicle Stimulating Hormone Market report?

Ans: The Applications covered in the Follicle Stimulating Hormone Market report are Infertility Treatment, Assisted Reproductive Technology

What are the Type segmentation covered in the Follicle Stimulating Hormone Market report?

Ans: The Types covered in the Follicle Stimulating Hormone Market report are Recombinant FSH, Urinary FSH

1 Follicle Stimulating Hormone Market Overview
1.1 Product Definition
1.2 Follicle Stimulating Hormone by Type
1.2.1 Global Follicle Stimulating Hormone Market Value by Type: 2025 vs 2032
1.2.2 Recombinant FSH
1.2.3 Urinary FSH
1.3 Follicle Stimulating Hormone by Application
1.3.1 Global Follicle Stimulating Hormone Market Value by Application: 2025 vs 2032
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Global Follicle Stimulating Hormone Market Size Estimates and Forecasts
1.4.1 Global Follicle Stimulating Hormone Revenue 2021–2032
1.4.2 Global Follicle Stimulating Hormone Sales 2021–2032
1.4.3 Global Follicle Stimulating Hormone Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Follicle Stimulating Hormone Market Competition by Manufacturers
2.1 Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2021–2026)
2.2 Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Follicle Stimulating Hormone Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Follicle Stimulating Hormone, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Follicle Stimulating Hormone, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Follicle Stimulating Hormone, Product Types and Applications
2.7 Global Key Manufacturers of Follicle Stimulating Hormone, Date of Entry into the Industry
2.8 Global Follicle Stimulating Hormone Market Competitive Situation and Trends
2.8.1 Global Follicle Stimulating Hormone Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Follicle Stimulating Hormone Players Market Share by Revenue
2.8.3 Global Follicle Stimulating Hormone Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Follicle Stimulating Hormone Market Scenario by Region
3.1 Global Follicle Stimulating Hormone Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Follicle Stimulating Hormone Sales by Region: 2021–2032
3.2.1 Global Follicle Stimulating Hormone Sales by Region: 2021–2026
3.2.2 Global Follicle Stimulating Hormone Sales by Region: 2027–2032
3.3 Global Follicle Stimulating Hormone Revenue by Region: 2021–2032
3.3.1 Global Follicle Stimulating Hormone Revenue by Region: 2021–2026
3.3.2 Global Follicle Stimulating Hormone Revenue by Region: 2027–2032
3.4 North America Follicle Stimulating Hormone Market Facts & Figures by Country
3.4.1 North America Follicle Stimulating Hormone Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Follicle Stimulating Hormone Sales by Country (2021–2032)
3.4.3 North America Follicle Stimulating Hormone Revenue by Country (2021–2032)
3.5 Europe Follicle Stimulating Hormone Market Facts & Figures by Country
3.5.1 Europe Follicle Stimulating Hormone Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Follicle Stimulating Hormone Sales by Country (2021–2032)
3.5.3 Europe Follicle Stimulating Hormone Revenue by Country (2021–2032)
3.5.4 Poland
3.6 Asia Pacific Follicle Stimulating Hormone Market Facts & Figures by Region
3.6.1 Asia Pacific Follicle Stimulating Hormone Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Follicle Stimulating Hormone Sales by Region (2021–2032)
3.6.3 Asia Pacific Follicle Stimulating Hormone Revenue by Region (2021–2032)
3.7 Latin America Follicle Stimulating Hormone Market Facts & Figures by Country
3.7.1 Latin America Follicle Stimulating Hormone Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Follicle Stimulating Hormone Sales by Country (2021–2032)
3.7.3 Latin America Follicle Stimulating Hormone Revenue by Country (2021–2032)
3.8 Middle East and Africa Follicle Stimulating Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Follicle Stimulating Hormone Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Follicle Stimulating Hormone Sales by Country (2021–2032)
3.8.3 Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2021–2032)
4 Segment by Type
4.1 Global Follicle Stimulating Hormone Sales by Type (2021–2032)
4.1.1 Global Follicle Stimulating Hormone Sales by Type (2021–2026)
4.1.2 Global Follicle Stimulating Hormone Sales by Type (2027–2032)
4.1.3 Global Follicle Stimulating Hormone Sales Market Share by Type (2021–2032)
4.2 Global Follicle Stimulating Hormone Revenue by Type (2021–2032)
4.2.1 Global Follicle Stimulating Hormone Revenue by Type (2021–2026)
4.2.2 Global Follicle Stimulating Hormone Revenue by Type (2027–2032)
4.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Type (2021–2032)
4.3 Global Follicle Stimulating Hormone Price by Type (2021–2032)
5 Segment by Application
5.1 Global Follicle Stimulating Hormone Sales by Application (2021–2032)
5.1.1 Global Follicle Stimulating Hormone Sales by Application (2021–2026)
5.1.2 Global Follicle Stimulating Hormone Sales by Application (2027–2032)
5.1.3 Global Follicle Stimulating Hormone Sales Market Share by Application (2021–2032)
5.2 Global Follicle Stimulating Hormone Revenue by Application (2021–2032)
5.2.1 Global Follicle Stimulating Hormone Revenue by Application (2021–2026)
5.2.2 Global Follicle Stimulating Hormone Revenue by Application (2027–2032)
5.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Application (2021–2032)
5.3 Global Follicle Stimulating Hormone Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Company Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 MSD
6.2.1 MSD Company Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 MSD Follicle Stimulating Hormone Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 IBSA
6.3.1 IBSA Company Information
6.3.2 IBSA Description and Business Overview
6.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
6.3.5 IBSA Recent Developments/Updates
6.4 Ferring
6.4.1 Ferring Company Information
6.4.2 Ferring Description and Business Overview
6.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
6.4.5 Ferring Recent Developments/Updates
6.5 Livzon
6.5.1 Livzon Company Information
6.5.2 Livzon Description and Business Overview
6.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
6.5.5 Livzon Recent Developments/Updates
6.6 Techwell
6.6.1 Techwell Company Information
6.6.2 Techwell Description and Business Overview
6.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
6.6.5 Techwell Recent Developments/Updates
6.7 GenSci
6.7.1 GenSci Company Information
6.7.2 GenSci Description and Business Overview
6.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 GenSci Follicle Stimulating Hormone Product Portfolio
6.7.5 GenSci Recent Developments/Updates
6.8 Gedeon Richter
6.8.1 Gedeon Richter Company Information
6.8.2 Gedeon Richter Description and Business Overview
6.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
6.8.5 Gedeon Richter Recent Developments/Updates
6.9 Teva
6.9.1 Teva Company Information
6.9.2 Teva Description and Business Overview
6.9.3 Teva Follicle Stimulating Hormone Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Teva Follicle Stimulating Hormone Product Portfolio
6.9.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Follicle Stimulating Hormone Industry Chain Analysis
7.2 Follicle Stimulating Hormone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Follicle Stimulating Hormone Production Mode & Process Analysis
7.4 Follicle Stimulating Hormone Sales and Marketing
7.4.1 Follicle Stimulating Hormone Sales Channels
7.4.2 Follicle Stimulating Hormone Distributors
7.5 Follicle Stimulating Hormone Customer Analysis
8 Follicle Stimulating Hormone Market Dynamics
8.1 Follicle Stimulating Hormone Industry Trends
8.2 Follicle Stimulating Hormone Market Drivers
8.3 Follicle Stimulating Hormone Market Challenges
8.4 Follicle Stimulating Hormone Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck Serono
MSD
IBSA
Ferring
LIVZON
Techwell
GenSci
Gedeon Richter
TEVA
List of Tables
 Table 1. Global Follicle Stimulating Hormone Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Follicle Stimulating Hormone Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Follicle Stimulating Hormone Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Follicle Stimulating Hormone Sales (K Doses) of Key Manufacturers (2021–2026)
 Table 5. Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Follicle Stimulating Hormone Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Follicle Stimulating Hormone Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Follicle Stimulating Hormone Average Price (USD/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Follicle Stimulating Hormone, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Follicle Stimulating Hormone, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Follicle Stimulating Hormone, Product Types and Applications
 Table 12. Global Key Manufacturers of Follicle Stimulating Hormone, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Follicle Stimulating Hormone Companies by Tier (Tier 1, Tier 2, Tier 3), based on Follicle Stimulating Hormone Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Follicle Stimulating Hormone Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Follicle Stimulating Hormone Sales by Region (K Doses), 2021–2026
 Table 18. Global Follicle Stimulating Hormone Sales Market Share by Region (2021–2026)
 Table 19. Global Follicle Stimulating Hormone Sales by Region (K Doses), 2027–2032
 Table 20. Global Follicle Stimulating Hormone Sales Market Share by Region (2027–2032)
 Table 21. Global Follicle Stimulating Hormone Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Follicle Stimulating Hormone Revenue Market Share by Region (2021–2026)
 Table 23. Global Follicle Stimulating Hormone Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Follicle Stimulating Hormone Revenue Market Share by Region (2027–2032)
 Table 25. North America Follicle Stimulating Hormone Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Follicle Stimulating Hormone Sales by Country (K Doses), 2021–2026
 Table 27. North America Follicle Stimulating Hormone Sales by Country (K Doses), 2027–2032
 Table 28. North America Follicle Stimulating Hormone Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Follicle Stimulating Hormone Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Follicle Stimulating Hormone Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Follicle Stimulating Hormone Sales by Country (K Doses), 2021–2026
 Table 32. Europe Follicle Stimulating Hormone Sales by Country (K Doses), 2027–2032
 Table 33. Europe Follicle Stimulating Hormone Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Follicle Stimulating Hormone Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Follicle Stimulating Hormone Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Follicle Stimulating Hormone Sales by Region (K Doses), 2021–2026
 Table 37. Asia Pacific Follicle Stimulating Hormone Sales by Region (K Doses), 2027–2032
 Table 38. Asia Pacific Follicle Stimulating Hormone Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Follicle Stimulating Hormone Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Follicle Stimulating Hormone Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Follicle Stimulating Hormone Sales by Country (K Doses), 2021–2026
 Table 42. Latin America Follicle Stimulating Hormone Sales by Country (K Doses), 2027–2032
 Table 43. Latin America Follicle Stimulating Hormone Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Follicle Stimulating Hormone Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Follicle Stimulating Hormone Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Follicle Stimulating Hormone Sales by Country (K Doses), 2021–2026
 Table 47. Middle East and Africa Follicle Stimulating Hormone Sales by Country (K Doses), 2027–2032
 Table 48. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Follicle Stimulating Hormone Sales (K Doses) by Type (2021–2026)
 Table 51. Global Follicle Stimulating Hormone Sales (K Doses) by Type (2027–2032)
 Table 52. Global Follicle Stimulating Hormone Sales Market Share by Type (2021–2026)
 Table 53. Global Follicle Stimulating Hormone Sales Market Share by Type (2027–2032)
 Table 54. Global Follicle Stimulating Hormone Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Follicle Stimulating Hormone Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Follicle Stimulating Hormone Revenue Market Share by Type (2021–2026)
 Table 57. Global Follicle Stimulating Hormone Revenue Market Share by Type (2027–2032)
 Table 58. Global Follicle Stimulating Hormone Price (USD/Dose) by Type (2021–2026)
 Table 59. Global Follicle Stimulating Hormone Price (USD/Dose) by Type (2027–2032)
 Table 60. Global Follicle Stimulating Hormone Sales (K Doses) by Application (2021–2026)
 Table 61. Global Follicle Stimulating Hormone Sales (K Doses) by Application (2027–2032)
 Table 62. Global Follicle Stimulating Hormone Sales Market Share by Application (2021–2026)
 Table 63. Global Follicle Stimulating Hormone Sales Market Share by Application (2027–2032)
 Table 64. Global Follicle Stimulating Hormone Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Follicle Stimulating Hormone Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Follicle Stimulating Hormone Revenue Market Share by Application (2021–2026)
 Table 67. Global Follicle Stimulating Hormone Revenue Market Share by Application (2027–2032)
 Table 68. Global Follicle Stimulating Hormone Price (USD/Dose) by Application (2021–2026)
 Table 69. Global Follicle Stimulating Hormone Price (USD/Dose) by Application (2027–2032)
 Table 70. Merck Serono Company Information
 Table 71. Merck Serono Description and Business Overview
 Table 72. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 73. Merck Serono Follicle Stimulating Hormone Product
 Table 74. Merck Serono Recent Developments/Updates
 Table 75. MSD Company Information
 Table 76. MSD Description and Business Overview
 Table 77. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 78. MSD Follicle Stimulating Hormone Product
 Table 79. MSD Recent Developments/Updates
 Table 80. IBSA Company Information
 Table 81. IBSA Description and Business Overview
 Table 82. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 83. IBSA Follicle Stimulating Hormone Product
 Table 84. IBSA Recent Developments/Updates
 Table 85. Ferring Company Information
 Table 86. Ferring Description and Business Overview
 Table 87. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 88. Ferring Follicle Stimulating Hormone Product
 Table 89. Ferring Recent Developments/Updates
 Table 90. Livzon Company Information
 Table 91. Livzon Description and Business Overview
 Table 92. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 93. Livzon Follicle Stimulating Hormone Product
 Table 94. Livzon Recent Developments/Updates
 Table 95. Techwell Company Information
 Table 96. Techwell Description and Business Overview
 Table 97. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 98. Techwell Follicle Stimulating Hormone Product
 Table 99. Techwell Recent Developments/Updates
 Table 100. GenSci Company Information
 Table 101. GenSci Description and Business Overview
 Table 102. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 103. GenSci Follicle Stimulating Hormone Product
 Table 104. GenSci Recent Developments/Updates
 Table 105. Gedeon Richter Company Information
 Table 106. Gedeon Richter Description and Business Overview
 Table 107. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 108. Gedeon Richter Follicle Stimulating Hormone Product
 Table 109. Gedeon Richter Recent Developments/Updates
 Table 110. Teva Company Information
 Table 111. Teva Description and Business Overview
 Table 112. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 113. Teva Follicle Stimulating Hormone Product
 Table 114. Teva Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Follicle Stimulating Hormone Distributors List
 Table 118. Follicle Stimulating Hormone Customers List
 Table 119. Follicle Stimulating Hormone Market Trends
 Table 120. Follicle Stimulating Hormone Market Drivers
 Table 121. Follicle Stimulating Hormone Market Challenges
 Table 122. Follicle Stimulating Hormone Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Follicle Stimulating Hormone
 Figure 2. Global Follicle Stimulating Hormone Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Follicle Stimulating Hormone Market Share by Type: 2025 & 2032
 Figure 4. Recombinant FSH Product Picture
 Figure 5. Urinary FSH Product Picture
 Figure 6. Global Follicle Stimulating Hormone Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Follicle Stimulating Hormone Market Share by Application: 2025 & 2032
 Figure 8. Infertility Treatment
 Figure 9. Assisted Reproductive Technology
 Figure 10. Global Follicle Stimulating Hormone Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Follicle Stimulating Hormone Market Size (US$ Million), 2021–2032
 Figure 12. Global Follicle Stimulating Hormone Sales (K Doses), 2021–2032
 Figure 13. Global Follicle Stimulating Hormone Average Price (USD/Dose), 2021–2032
 Figure 14. Follicle Stimulating Hormone Report Years Considered
 Figure 15. Follicle Stimulating Hormone Sales Share by Manufacturers in 2025
 Figure 16. Global Follicle Stimulating Hormone Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Follicle Stimulating Hormone Players: Market Share by Revenue in Follicle Stimulating Hormone in 2025
 Figure 18. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Follicle Stimulating Hormone Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Follicle Stimulating Hormone Sales Market Share by Country (2021–2032)
 Figure 21. North America Follicle Stimulating Hormone Revenue Market Share by Country (2021–2032)
 Figure 22. Europe Follicle Stimulating Hormone Sales Market Share by Country (2021–2032)
 Figure 23. Europe Follicle Stimulating Hormone Revenue Market Share by Country (2021–2032)
 Figure 24. Poland Follicle Stimulating Hormone Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Region (2021–2032)
 Figure 26. Asia Pacific Follicle Stimulating Hormone Revenue Market Share by Region (2021–2032)
 Figure 27. Latin America Follicle Stimulating Hormone Sales Market Share by Country (2021–2032)
 Figure 28. Latin America Follicle Stimulating Hormone Revenue Market Share by Country (2021–2032)
 Figure 29. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Country (2021–2032)
 Figure 30. Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Country (2021–2032)
 Figure 31. Global Sales Market Share of Follicle Stimulating Hormone by Type (2021–2032)
 Figure 32. Global Revenue Market Share of Follicle Stimulating Hormone by Type (2021–2032)
 Figure 33. Global Follicle Stimulating Hormone Price (USD/Dose) by Type (2021–2032)
 Figure 34. Global Sales Market Share of Follicle Stimulating Hormone by Application (2021–2032)
 Figure 35. Global Revenue Market Share of Follicle Stimulating Hormone by Application (2021–2032)
 Figure 36. Global Follicle Stimulating Hormone Price (USD/Dose) by Application (2021–2032)
 Figure 37. Follicle Stimulating Hormone Value Chain
 Figure 38. Channels of Distribution (Direct Vs Distribution)
 Figure 39. Bottom-up and Top-down Approaches for This Report
 Figure 40. Data Triangulation
 Figure 41. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Global Recombinant FSH Injections Market Research Report 2024
Recombinant Human Follicle stimulating Hormone Market
Global Follicle Stimulating Hormone Test Kit Market Research Report 2024
Recombinant Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Follitropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Reproductive Hormone Market Insights Forecast to 2030
Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2024
Global Injectable Reproductive Hormone Market Insights Forecast to 2030
Global Serum Gonadotrophin for Injection Market Research Report 2024
Global Follicle Stimulating Hormone FSH ELISA Test Kit Market Research Report 2024
Gonadotropin releasing Hormone Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urinary Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luteinizing Hormone releasing Hormone Analogs Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luteinizing Hormone releasing Hormone Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global FSH Test Kit Market Research Report 2024
Global Human Growth Hormone Market Research Report 2025
Global GnRH Agonist Market Research Report 2024
Global Veterinary Follicle Stimulating Hormones FSH Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions